ABBOTT LABORATORIES — Director's Dealing 2016

Apr 1, 2016

SEC FORM 4 Page 1 of 2

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

| 1. Name and Address of Reporting Person Contreras Jaime | | 2. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ] | | | | | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (Last) (First) (Middle) 100 ABBOTT PARK ROAD | | 3. Date of Earliest Transaction (Month/Day/Year) 03/31/2016 | | | | | | | | | (Street) ABBOTT PARK IL 60064 | | 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | | | | | | | | (City) (State) (Zip) | | | | | | | | | | | Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | | | | | | | | | | | 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | | | 5. Amount of Securities Beneficially Owned Following Reported Transaction (s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | | | | | Code | V | Amount | (A) or (D) | Price | | | | Common shares without par value | | | | | | | | 47,667 | D | | Common shares without par value | | | | | | | | 21 (1) | I | | Common shares without par value | | | | | | | | 63,903 (2) | I | | Common shares without par value | 03/31/2016 | | A | | 1,406 (3) | A | $0 | 3,100 (4) | I | | Common shares without par value | 03/31/2016 | | F | | 212 | D | $41.65 | 2,888 | I | | Common shares without par value | 03/31/2016 | | S | | 162 | D | $41.7842 | 2,726 | I | | Common shares without par value | 03/31/2016 | | S | | 162 | D | $41.785 | 2,564 | I | | Common shares without par value | 03/31/2016 | | S | | 138 | D | $41.7842 | 2,426 | I | | Common shares without par value | | | | | | | | 12,081 (5) | I |

http://www.sec.gov/Archives/edgar/data/1800/000117911016022538/xslF345X03/edgar.xml

---

SEC FORM 4 Page 2 of 2

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction (s) (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2016.
2. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
3. This grant represents a restricted stock unit award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have shares withheld for tax purposes.
4. The reporting person disclaims beneficial ownership of all securities held by his spouse.
5. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

Remarks:

The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of attorney for Jaime Contreras 04/01/2016

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911016022538/xslF345X03/edgar.xml 4/1/2016